Key points from article :
Five Alarm Bio (FAB) has completed a seed investment round, raising over £500K GBP to further enable its pioneering research.
Investors participating in the round include Cambridge Angels, Meltwind, o2h Ventures, and SyndicateRoom.
FAB is developing an innovative small molecule approach aimed at boosting our defences as we age.
Investment will enable further testing of new compounds for their ability to extend the healthy lifespan of cells in vitro.
These compounds have the potential to delay or prevent the onset of a broad range of age-related diseases.
“FAB is at the forefront of the rapidly growing anti-aging therapeutics industry," - Sunil Shah, Co-founder, Five Alarm Bio, and CEO, o2h Ventures.
